产品说明书
Cefmetazole sodium
 |
同义名 : | Sodium cefmetazole |
| CAS号 : | 56796-39-5 | |
| 货号 : | A537216 | |
| 分子式 : | C15H16N7NaO5S3 | |
| 纯度 : | 98% | |
| 分子量 : | 493.516 | |
| MDL号 : | MFCD00214260 | |
| 存储条件： |
粉末 Inert atmosphere,2-8°C 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 120 mg/mL(243.15 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO H2O: 100 mg/mL(202.63 mM)，配合低频超声助溶 |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | Cefmetazole sodium is a semisynthetic cephamycin antibiotic. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01112436 | Femoral Neck Fracture | Phase 4 | Unknown | April 2012 | Korea, Republic of ... 展开 >> ChungAng University Recruiting Seoul, Korea, Republic of, 156-755 Contact: SeongDeok Kim, M.D. & Ph.D. +82-2-6299-2571 ksdeok@cau.ac.kr Principal Investigator: Yong Chan Ha, M.D. & Ph.D. Sub-Investigator: Hyun Kang, M.D & PH.D 收起 << |
| NCT00292708 | Colorectal Surgery | Phase 3 | Completed | - | Japan ... 展开 >> Ishikawa Prefectural Central Hospital Kanazawa, Japan National Cancer Center East Hospital Kashiwa, Japan Nagoya Medical Center Nagoya, Japan Niigata Cancer Center Hospital Niigata, Japan Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka, Japan National Cancer Center Hospital Tokyo, Japan Yamagata Prefectural Central Hospital Yamagata, Japan 收起 << |
| NCT00508690 | Colorectal Neoplasms | Phase 3 | Completed | - | Japan ... 展开 >> Tenriyorozu Hospital Tenri, Nara, Japan, 6328552 Kyoto Univercity Hospital Kyoto, Japan, 606-8507 National Hospital Organization, Kyoto Medical Center Kyoto, Japan, 612-8555 Kyoto Katsura Hospital Kyoto, Japan, 6158256 Kitano Hospital Osaka, Japan, 5308480 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.03mL 0.41mL 0.20mL |
10.13mL 2.03mL 1.01mL |
20.26mL 4.05mL 2.03mL |
| 参考文献 |
|---|